NCT00143689View on ClinicalTrials.gov

NRTI-Sparing Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
HIVMitochondrial Toxicity
Interventions
DRUG

lopinavir/ritonavir; nevirapine; Zidovudine; Lamivudine

See Detailed Description.

Trial Locations (4)

Unknown

McMaster University, Hamilton

University of Ottawa Health Services, Ottawa

Maple Leaf Clinic, Toronto

Clinique Medicale L'Actuel, Montreal

Sponsors
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

CIHR Canadian HIV Trials Network

NETWORK

lead

University of British Columbia

OTHER